Fortrea Assina Contrato Definitivo de Transferência das Unidades Endpoint Clinical e Patient Access para a Arsenal Capital Partners

A proposta da transferência das unidades Endpoint Clinical e Fortrea Patient Access agiliza ainda mais o foco estratégico da Fortrea como uma organização de pesquisa sob contrato

Ela cria as melhores soluções independentes de Randomização e Gestão de Fornecimento de Ensaios e Acesso do Paciente posicionadas para diferenciação e crescimento

DURHAM, N.C., March 12, 2024 (GLOBE NEWSWIRE) — A Fortrea (Nasdaq: FTRE) (a “Empresa”), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje que assinou um contrato definitivo de transferência dos ativos relacionados ao seu segmento Enabling Services, ou seja, suas unidades Endpoint Clinical (“Endpoint”) e Fortrea Patient Access, para a Arsenal Capital Partners (“Arsenal”), uma empresa líder de private equity especializada na criação de empresas de saúde líderes de mercado e ricas em tecnologia.

Com a transferência dessas unidades, a Fortrea visa promover a estratégia de crescimento e soluções da Endpoint e da Fortrea Patient Access, posicionando-as para aumentar o investimento para acelerar o roteiro de tecnologia e aprimorar ainda mais as operações para apoiar as melhores soluções e entregas aos clientes. As outras unidades da Fortrea irão fortalecer seu foco nas fases de desenvolvimento clínico 1 a 4. A conclusão da transação está prevista para o segundo trimestre de 2024, estando sujeita às condições habituais de fechamento e aprovações regulatórias, bem como às partes que celebram certos serviços e contratos operacionais.

“Hoje é um marco significativo na jornada contínua da Fortrea, à medida que aprimoramos nosso foco em crescer organicamente como uma CRO pura, com flexibilidade financeira adicional”, disse o presidente e CEO da Fortrea, Tom Pike. “Depois de uma revisão estratégica de nossos negócios, concluímos que a transferência das unidades Endpoint e Fortrea Patient Access se alinha aos interesses dos nossos clientes. A Arsenal tem uma vasta experiência na criação de empresas que criam melhorias sistemáticas nos resultados de saúde, e estou confiante de que a Endpoint e a Fortrea Patient Access poderão fortalecer suas posições no mercado, cultivar talentos de primeira linha e investir em novas capacidades e recursos, ao mesmo tempo, oferecer soluções que melhoram a vida dos pacientes.”

“Estou muito entusiasmado com este próximo capítulo da Endpoint e a Fortrea Patient Access”, disse Sam Osman, presidente da Enabling Services da Fortrea, que atuará como CEO dessas empresas com a Arsenal. “Essas empresas estarão distintamente posicionadas para gerenciar efetivamente a jornada do paciente nos ensaios clínicos e na comercialização, impulsionando o acesso e a adesão do paciente às terapias aprovadas. Com a união da profunda perspicácia de investimento da Arsenal com a experiência operacional líder do setor, estou confiante de que as empresas Endpoint e Fortrea Patient Access estão bem posicionadas para o crescimento e a entrega de recursos aprimorados para pacientes e patrocinadores farmacêuticos. Quero dar continuidade ao impacto positivo no cuidado da saúde.”

“A Endpoint e a Fortrea Patient Access têm um histórico orgulhoso de décadas de liderança no mercado no apoio à pesquisa clínica e comercialização de terapias inovadoras. A Arsenal tem orgulho em criar organizações que melhoram significativamente os cuidados da saúde. Estamos entusiasmados com a parceria com a administração e os funcionários para acelerar o crescimento desses dois negócios”, disse Gene Gorbach, um Parceiro de Investimento da Arsenal.

Dimitris Agrafiotis, Ph.D., Diretor de Digital, Análise e IA da Arsenal, disse: “A Endpoint e a Fortrea Patient Access fornecem soluções essenciais que permitem a participação dos pacientes em ensaios clínicos e acesso a terapias. Tenho o prazer de apoiar a equipe talentosa da Endpoint e da Fortrea Patient Access. Juntos, aumentaremos ainda mais a sofisticação das capacidades tecnológicas que sustentam o compromisso dessas empresas em fornecer serviços da mais alta qualidade para a indústria farmacêutica.”

Endpoint Clinical
A Endpoint opera no mercado eClinical de alto crescimento como provedora líder de soluções de Randomização e Gerenciamento de Fornecimento de Ensaios (RTSM) para clientes biofarmacêuticos e CRO, com experiência no atendimento de ensaios clínicos complexos e em estágio avançado. Com mais de 15 anos, a Endpoint já apoiou com sucesso mais de 1.750 ensaios clínicos envolvendo 875.000 pacientes em 90 países e cultivou uma base de clientes de primeira linha e relacionamentos estratégicos de longa data.

Fortrea Patient Access
A Fortrea Patient Access é uma líder em escala no mercado de serviços de HUB e acesso do paciente, atendendo à indústria biofarmacêutica com suporte abrangente ao paciente, acesso ao produto, acessibilidade e soluções de adesão há mais de 30 anos. Avançando ainda mais com sua especializada farmácia não comercial recentemente expandida, a FortreaRx™, para apoiar a distribuição aprimorada de produtos de cadeia fria e sem ambiente, a Fortrea Patient Access está comprometida em impulsionar os resultados dos pacientes e aprimorar a acessibilidade aos cuidados da saúde por meio da sua ampla experiência, oferecendo suporte a mais de 2,5 milhões de pacientes e mais de 100 marcas exclusivas para mais de 25 indicações de doenças.

Arsenal Capital Partners
A Arsenal Capital Partners é uma empresa líder em investimentos em patrimônio privado especializada na criação de empresas líderes de mercado em crescimento industrial e saúde. Desde a sua criação em 2000, o Arsenal levantou fundos de investimento de capital institucional com um total de mais de US$ 10 bilhões, concluiu mais de 290 aquisições de plataformas e complementos, e alcançou mais de 35 realizações. A empresa trabalha com equipes de gestão para criar empresas estrategicamente importantes com posições de liderança no mercado, alto crescimento e alto valor agregado. Para mais informação, visite www.arsenalcapital.com.

Consultores
Barclays está atuando como consultor financeiro exclusivo da Fortrea, e Smith Anderson como consultor jurídico. A Sidley Austin LLP atuou como consultora jurídica da Arsenal.

Chamada e Replay de Ganhos
A Fortrea discutirá o anúncio da transferência na sua teleconferência de resultados do quarto trimestre de 2023, que será realizada hoje às 9h ET. A conferência pode ser acessada no site Investor Relations da Fortrea (Relacionamento com o Investidor) ou no seguinte link earnings webcast (Webcast de ganhos). Para evitar possíveis atrasos, acesse pelo menos 10 minutos antes do início da chamada. Um replay da teleconferência ao vivo estará disponível logo após a conclusão do evento e acessível na seção events and presentationts (eventos e apresentações) do site da Fortrea. Uma apresentação de slides suplementar também estará disponível no site Investor Relations da Fortrea antes do início da chamada.

Sobre a Fortrea
A Fortrea (Nasdaq: FTRE) é fornecedora líder global de soluções para o desenvolvimento clínico e acesso ao paciente para a indústria de ciências da vida. Fazemos parcerias com grandes e emergentes empresas biofarmacêuticas, de biotecnologia, de dispositivos médicos e de diagnóstico para impulsionar a inovação na saúde que acelera terapias que mudam a vida dos pacientes. A Fortrea fornece gerenciamento de testes clínicos de fase I-IV, farmacologia clínica, serviços de consultoria, soluções de testes com tecnologia diferenciada e serviços pós-aprovação. As soluções da Fortrea utilizam suas três décadas de experiência abrangendo mais de 20 áreas terapêuticas, sua dedicação ao rigor científico, insights excepcionais e uma forte rede de pesquisadores. Nossa equipe talentosa e diversificada de aproximadamente 18.000 pessoas que trabalham em mais de 90 países é dimensionada para fornecer soluções focadas e ágeis para clientes de todo o mundo. Saiba mais sobre como a Fortrea está se tornando uma força transformadora de pipeline para paciente na Fortrea.com e siga-nos no LinkedIn e X (antigo Twitter) @Fortrea.

Advertência a Respeito de Declarações de Previsão

Este comunicado contém “declarações de previsão” de acordo com a definição do termo estabelecido na Seção 27A da Lei de Valores Mobiliários (Securities Act) e na Seção 21E da Lei de Mercados Mobiliários (Securities Exchange Act). As declarações de previsão, por sua natureza, abordam questões que são, em diferentes graus, incertas, como as declarações sobre os benefícios previstos da transação, incluindo o desempenho financeiro e operacional futuro, e o prazo previsto para a conclusão da transação. Neste contexto, as declarações de previsão geralmente abordam o desempenho futuro esperado e o desempenho financeiro e a condição financeira, e muitas vezes contêm palavras como “orientação”, “esperar”, “supor”, “antecipar”, “pretender”, “planejar”, “prever”, “acreditar”, “buscar”, “ver”, “irá”, “faria”, “alvo”, expressões semelhantes e variações ou negativos dessas palavras que se destinam a identificar declarações de previsão, embora nem todas as declarações de previsão contenham essas palavras de identificação. Os resultados reais podem diferir materialmente dessas declarações de previsão devido a uma série de fatores, incluindo, mas não se limitando a: satisfação das condições precedentes à consumação da transferência proposta da transação das unidades Endpoint Clinical e Fortrea Patient Access, incluindo a capacidade de garantir aprovações regulatórias e a capacidade da Empresa de concluir a transação em tempo hábil ou de alguma forma; a possibilidade de que a transação possa ser mais cara do que o previsto, inclusive como resultado de fatores ou eventos inesperados; a capacidade das partes de atender às expectativas em relação aos tratamentos contábeis e fiscais da transação proposta; e outros fatores descritos ocasionalmente nos documentos que a Empresa arquiva junto à SEC. Para uma discussão mais aprofundada dos riscos relacionados aos negócios da Empresa, consulte a Seção “Fatores de Risco” da Declaração de Registro da Empresa no Formulário 10, conforme arquivado na Comissão de Valores Mobiliários (a “SEC”), pois tais fatores podem ser alterados ou atualizados ocasionalmente nos registros periódicos e outros registros subsequentes da Empresa na SEC, acessíveis no site da SEC em www.sec.gov. Esses fatores não devem ser interpretados como exaustivos e devem ser lidos em conjunto com as outras declarações de advertência incluídas ou incorporadas por referência neste relatório e nos registros da Empresa na SEC. As declarações de previsão incluídas neste comunicado são válidas apenas a partir da presente data e não assumimos nenhuma obrigação de atualizar essas declarações de previsão para indicar eventos ou acontecimentos subsequentes.

Contatos da Fortrea:
Hima Inguva (Investidores) – 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek (Mídia) – 919-943-5422, media@fortrea.com
Kate Dillon (Mídia) – 646-818-9115, kdillon@prosek.com

Contato da Arsenal:
Jackie Schofield, pro-Arsenal@prosek.com

GlobeNewswire Distribution ID 9062251

Fortrea signe un accord définitif pour céder les activités Endpoint Clinical et Patient Access à Arsenal Capital Partners

Le projet de cession des activités Endpoint Clinical et Fortrea Patient Access permet à Fortrea de se recentrer sur son cœur de métier stratégique d’organisme de recherche contractuelle

Création de solutions autonomes de premier ordre pour la randomisation, la gestion de l’approvisionnement des essais et l’accès des patients, positionnées pour la différenciation et la croissance

DURHAM, État de Caroline du Nord, 12 mars 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq : FTRE) (la « Société »), un organisme de recherche sous contrat (« ORC ») de premier plan au niveau mondial, a annoncé aujourd’hui la signature d’un accord définitif de cession des actifs liés à son segment Enabling Services, à savoir ses activités Endpoint Clinical (ci-après « Endpoint ») et Fortrea Patient Access, à Arsenal Capital Partners (« Arsenal »), une société de capital-investissement de premier plan spécialisée dans la création d’entreprises de soins de santé leaders sur le marché et à fort profil technologique.

En cédant ces activités, Fortrea vise à faire progresser la stratégie de croissance et les solutions Endpoint et Fortrea Patient Access, en les positionnant de sorte à attirer davantage d’investissements afin d’accélérer la feuille de route technologique et d’améliorer encore les opérations pour soutenir les meilleures solutions et prestations pour les clients. Les activités restantes de Fortrea se concentreront davantage sur les phases de développement clinique 1 à 4. La conclusion de la transaction est prévue pour le deuxième trimestre 2024, sous réserve des conditions de finalisation habituelles et des approbations réglementaires, ainsi que de la conclusion par les parties de certains accords de services et d’exploitation.

« Ce jour marque une étape importante dans l’histoire de Fortrea, à l’heure où nous renforçons nos efforts en vue de croître organiquement comme un ORC à part entière, avec une bien plus grande souplesse financière », a déclaré Tom Pike, président-directeur général de Fortrea. « Après avoir procédé à un examen stratégique de nos activités, la cession d’Endpoint et de Fortrea Patient Access est conforme aux intérêts de nos clients. Arsenal a une grande expérience dans la création d’entreprises qui améliorent systématiquement les résultats en matière de santé, et je suis convaincu qu’Endpoint et Fortrea Patient Access seront en mesure de renforcer leur position sur le marché, de faire s’épanouir et grandir des talents de premier plan et d’investir dans de nouvelles capacités et ressources, tout en proposant des solutions qui améliorent la vie des patients. »

« Je me réjouis de ce nouveau chapitre qui s’écrit pour Endpoint et Fortrea Patient Access », a déclaré Sam Osman, président d’Enabling Services chez Fortrea, qui occupera le poste de PDG de ces entreprises avec Arsenal. « Ces entreprises seront particulièrement bien placées pour gérer efficacement le parcours du patient tout au long de la durée des essais cliniques, et ce, jusqu’à la commercialisation, en favorisant l’accès et l’adhésion des patients aux thérapies approuvées. En combinant les connaissances approfondies d’Arsenal en matière d’investissement et l’expertise opérationnelle du secteur, je suis convaincu que les activités d’Endpoint et de Fortrea Patient Access sont bien positionnées pour la croissance et la fourniture de capacités augmentées pour les patients et les promoteurs pharmaceutiques. Je me réjouis de l’impact positif que nous continuerons à avoir sur les soins de santé. »

« Endpoint et Fortrea Patient Access sont fiers de leur palmarès de plusieurs décennies en matière de leader sur le marché dans le soutien à la recherche clinique et à la commercialisation de thérapies innovantes. Arsenal est fier de créer des organisations qui améliorent de manière significative les soins de santé. Nous sommes ravis de nous associer à la direction et aux employés pour accélérer la croissance de ces deux entreprises », a déclaré Gene Gorbach, associé investisseur d’Arsenal.

Dimitris Agrafiotis, titulaire d’un doctorat, directeur du numérique, de l’analytique et de l’IA chez Arsenal, a déclaré : « Endpoint et Fortrea Patient Access fournissent des solutions essentielles qui permettent la participation des patients aux essais cliniques et l’accès aux thérapies. Je suis ravi de soutenir la talentueuse équipe d’Endpoint et de Fortrea Patient Access. Ensemble, nous allons encore améliorer la sophistication des capacités technologiques qui sous-tendent l’engagement de ces entreprises à fournir des services de la plus haute qualité à l’industrie pharmaceutique. »

Endpoint Clinical
Endpoint Clinical opère sur le marché à forte croissance de l’« eClinique » en tant que fournisseur de premier plan de solutions de randomisation et de gestion de l’approvisionnement des essais (« RTSM ») pour les clients biopharmaceutiques et les ORC, avec une expertise dans les essais cliniques complexes et en phase avancée de développement. Depuis plus de 15 ans, Endpoint a réussi à soutenir efficacement plus de 1 750 essais cliniques impliquant 875 000 patients dans 90 pays, à cultiver une clientèle de premier ordre et à entretenir des relations stratégiques de longue date.

Fortrea Patient Access
Fortrea Patient Access est un leader du marché des services HUB et de l’accès aux patients. Depuis plus de 30 ans, il propose à l’industrie biopharmaceutique des solutions complètes en matière de soutien aux patients, d’accès aux produits, d’accessibilité financière et d’observance. En outre, grâce à l’expansion récente de sa pharmacie spécialisée non commerciale, FortreaRx™, destinée à soutenir une distribution accrue des produits de la chaîne du froid et des produits gratuits à température ambiante, Fortrea Patient Access s’est engagée à améliorer les résultats pour les patients ainsi que l’accessibilité aux soins de santé, tout en soutenant actuellement plus de 2,5 millions de patients à travers plus de 100 marques uniques pour plus de 25 indications thérapeutiques.

Arsenal Capital Partners
Arsenal Capital Partners est une société de capital d’investissement privée de premier plan qui se spécialise dans la création d’entreprises industrielles de croissance et de soins de santé leaders sur le marché. Depuis sa création en 2000, Arsenal a levé des fonds d’investissement institutionnels d’un montant total de plus de 10 milliards de dollars, réalisé plus de 290 acquisitions de plateformes et d’actifs complémentaires, et plus de 35 cessions. La société travaille avec des équipes de gestion pour créer des entreprises d’importance stratégique avec des positions de leader sur le marché, une croissance élevée et une forte valeur ajoutée. Pour plus d’informations, rendez-vous sur www.arsenalcapital.com.

Conseillers
Barclays intervient en qualité de conseiller financier exclusif de Fortrea, et Smith Anderson comme son conseiller juridique. Sidley Austin LLP est intervenu en qualité de conseiller juridique d’Arsenal.

Conférence téléphonique de présentation des résultats et rediffusion
Fortrea discutera de l’annonce de la cession lors de sa conférence téléphonique sur les résultats du quatrième trimestre 2023, qui se tiendra aujourd’hui à 9 h, heure de l’Est. La conférence est accessible via le site Web des relations avec les investisseurs de Fortrea ou sur le lien redirigeant vers la webdiffusion des résultats. Pour éviter tout retard, veuillez vous inscrire au moins 10 minutes avant le début de l’appel. Une rediffusion de la conférence téléphonique en direct sera disponible peu après la fin de l’événement et accessible sur le site web de la Commission européenne, événements et présentations du site web de Fortrea U Un diaporama complémentaire sera également disponible sur le site Web des relations avec les investisseurs de Fortrea avant le début de la conférence téléphonique.

À propos de Fortrea
Fortrea (Nasdaq : FTRE) est l’un des principaux fournisseurs mondiaux de solutions de développement clinique et d’accès aux soins pour les patients dans le secteur des sciences de la vie. Fortrea s’associe à des sociétés établies et émergentes du domaine biopharmaceutique, de la biotechnologie des dispositifs médicaux et des diagnostics pour stimuler l’innovation en matière de santé, et accélérer la mise au point de traitements révolutionnaires pour les patients. Nous proposons des services de gestion d’essais cliniques de phase I à IV, de pharmacologie clinique, de services de consulting, d’essais différenciés axés sur des technologies habilitantes, et des services post-autorisation. Nos solutions s’appuient sur 30 ans d’expérience dans 20 domaines thérapeutiques, une passion pour la rigueur scientifique, des connaissances exceptionnelles et un solide réseau de centres de recherche. Notre équipe talentueuse et diversifiée d’environ 18 000 collaborateurs répartis sur plus de 90 pays est dimensionnée pour fournir des solutions ciblées et agiles à nos clients, partout dans le monde. Pour en savoir plus sur la manière dont Fortrea est un moteur d’influence du pipeline au patient, rendez-vous sur Fortrea.com et suivez-nous sur LinkedIn et X (anciennement Twitter) @Fortrea.

Mise en garde concernant les déclarations prospectives

Le présent communiqué de presse contient des « déclarations prospectives » au sens des lois fédérales sur les valeurs mobilières, notamment la Section 27A du Securities Act (la loi américaine sur les valeurs mobilières) et la Section 21E de l’Exchange Act (la loi américaine sur les Bourses de valeurs). Les déclarations prospectives traitent par nature de questions qui sont, à des degrés divers, incertaines, telles que les déclarations sur les avantages attendus de la transaction, y compris les performances financières et opérationnelles futures, ainsi que le calendrier prévu pour l’achèvement de la transaction. Dans ce contexte, les déclarations prospectives traitent souvent des performances commerciales et financières futures attendues et de la situation financière, et contiennent fréquemment des termes tels que « orientation », « s’attendre à », « supposer », « anticiper », « avoir l’intention », « planifier », « prévoir », « croire », « viser », « sera », « serait », « cible », des expressions similaires, ainsi que des variantes ou la forme négative de ces termes qui sont destinés à identifier les déclarations prospectives, bien que toutes les déclarations prospectives ne contiennent pas ces mots d’identification. Les résultats réels pourraient sensiblement différer de ces déclarations prospectives en raison d’un certain nombre de facteurs, y compris, mais sans s’y limiter : la satisfaction des conditions préalables à la réalisation de la transaction proposée pour la cession des activités Endpoint Clinical et Fortrea Patient Access, y compris la capacité à obtenir les autorisations réglementaires, ainsi que la capacité de la Société à réaliser la transaction dans les délais impartis ou à la réaliser en soi, la possibilité que la transaction soit plus coûteuse à réaliser que prévu, y compris en raison de facteurs ou d’événements inattendus, la capacité des parties à répondre aux attentes concernant les traitements comptables et fiscaux de la transaction proposée et d’autres facteurs décrits en tant que de besoin dans les documents que la Société dépose auprès de la Securities and Exchange Commission (« SEC »). Pour une analyse plus approfondie des risques liés à l’activité de la Société, voir la section « Facteurs de risque » de la Déclaration d’enregistrement de la Société sur le Formulaire 10, telle qu’elle a été déposée auprès de la SEC, ces facteurs pouvant être modifiés ou mis à jour en tant que de besoin dans les dépôts périodiques et autres de la Société introduits auprès de la SEC, qui sont accessibles sur le site Web de la SEC à l’adresse suivante : www.sec.gov. Ces facteurs ne doivent pas être considérés comme exhaustifs et doivent être lus conjointement avec les autres avertissements inclus ou incorporés par référence dans ce rapport et dans les documents déposés par la Société auprès de la SEC. Toutes les déclarations prospectives sont faites uniquement à la date du présent rapport et la Société ne s’engage pas, sauf si la loi l’exige, à mettre à jour ou à réviser les déclarations prospectives pour tenir compte d’événements ou de développements futurs.

Coordonnées de Fortrea :
Hima Inguva (Investisseurs) – 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek (Médias) – 919-943-5422, media@fortrea.com
Kate Dillon (Médias) – 646-818-9115, kdillon@prosek.com

Contact Arsenal :
Jackie Schofield : pro-Arsenal@prosek.com

GlobeNewswire Distribution ID 9062251

Latest Quantexa Decision Intelligence Platform Roadmap Puts Focus on Helping Enterprises and Government Agencies to Get Data Ready For AI

Microsoft and Quantexa announce partnership

 

Quantexa Limited

 Quantexa supporting rising wave of organizations using data, analytics, and AI to break down silos

  • Partnership with Microsoft makes Quantexa’s Decision Intelligence Platform immediately available on Microsoft Azure Marketplace; company commits to build solutions natively on Azure
  • Technology preview demonstrates Quantexa’s ambitious plan to accelerate platform, solution and generative AI adoption among business users, data, and IT professionals
  • Lighthouse customers take generative AI assistant, Q Assist™, into early adoption

LONDON, March 12, 2024 (GLOBE NEWSWIRE) — Quantexa, a global leader in decision intelligence solutions for the public and private sectors, used the backdrop of QuanCon24, its annual customer and partner conference, to reveal its Decision Intelligence Platform roadmap, and provided an update on Q Assist, a generative artificial intelligence (AI) assistant that previewed in July last year. Quantexa also announced a partnership with Microsoft. Dan Higgins, Quantexa’s Chief Product Officer, was joined by Kate Rosenshine, Global Technology Director, Strategic Partnerships at Microsoft, where they announced the immediate availability of Quantexa’s Decision Intelligence Platform on Microsoft Azure Marketplace and plans to bring a new cloud-native AI solution to mid-size banks in the United States.

Putting the Focus on Innovation and New Capabilities

Quantexa’s ambitious plan to lead the emerging decision intelligence category is anchored in helping enterprises and government agencies use contextual analytics and AI to improve organization-wide decision making. Quantexa is putting an emphasis on practical, real-world applicability today, with an eye on helping customers plan for future technology deployments. Gartner® predicts that “by 2027, 75% of new analytics content will be contextualized for intelligent applications through generative AI, enabling a composable connection between insights and actions.”*

As part of Quantexa’s growth strategy, the company showcased the platform’s ability to use AI to build a trusted data foundation and bring greater effectiveness to existing decisioning processes, while seamlessly integrating into customers’ existing technology infrastructure.

Dan Higgins, Quantexa’s Chief Product Officer, stated, “When it comes to Quantexa’s technology roadmap, we are guided by our client’s needs and leadership ambition in decision intelligence. This requires us to help our customers break down organizational silos to create a trusted data foundation, automate and augment decision making, and support continuous evaluation and improvement throughout decision processes. With the introduction of new capabilities and solutions, we remain steadfastly focused on delivering groundbreaking innovation that helps organizations protect, optimize, and grow.”

Quantexa Highlights Four Key Roadmap Pillars

  • Powering human/AI decisioning: Quantexa continues to pioneer solutions and tools to enable the use of multiple data sources and AI to automate business decision logic across various applications. Quantexa is updating its platform with enhanced workflow capabilities including new customizable scoring, alerting, and decisioning models. Quantexa debuted the platform’s new case management capabilities and an early adoption update to Q Assist, which is being deployed by customers in banking, telecommunications, and government agencies, in pilot programs to tackle financial crime, fraud, and risk, and to identify new revenue opportunities with customer intelligence.
  • Operationalizing data at scale with AI and contextual analytics: Quantexa’s ability to help customers build a trusted data foundation and gain single customer views remains a top driver of platform adoption. To meet increasing demand and unique industry complexities, Quantexa showcased advancements in data management, contextual analytics, and AI capabilities. Quantexa previewed the ability to move beyond news intelligence to support the ingestion and analysis of any unstructured data source via entity resolution and give the ability to customers to enable large-scale graph analysis and graph machine learning by combining large language models (LLMs) and knowledge graphs.
  • Accelerating time-to-value through simplified deployments and packaged solutions: Quantexa announced new options to make it easier for customers and partners to get up and running with new deployment methods, including the introduction of out-of-the box configurations as well as low-code and no-code tools. This year, Quantexa is also investing in accelerating the enablement of its growing ecosystem of partners, which includes PWC, EY, Dun & Bradstreet, KPMG, and Moody’s, who were presenting partners at QuanCon24.
  • Seamlessly integrating with customers’ existing technology stacks and processes: Quantexa’s Decision Intelligence Platform has an open and extensible architecture with scalable APIs and streamlined integrations with downstream applications and systems. Future efforts will focus on building a standardized framework and out-of-the-box connectors.

Quantexa brings its Decision Intelligence Platform and solutions to Azure with Microsoft partnership

A highlight of Quantexa’s Roadmap Session at today’s event was the announcement of Quantexa’s new partnership with Microsoft. Highlights included:

  • The immediate availability of Quantexa’s Decision Intelligence Platform on Azure Marketplace: Quantexa’s Decision Intelligence Platform is now available globally on Azure Marketplace for customers across financial services, the public sector, insurance, telecommunications, media and technology industries.
  • AI innovation aids mid-size banks in meeting regulatory and market pressures:
    Additionally, Quantexa detailed plans to build a new Azure native SaaS solution, allowing customers to deploy an end-to-end anti-money laundering (AML) transaction monitoring, investigations, and case management solution designed to take best-in-class capabilities used by the world’s largest banks into a tailored offering to meet the needs of financial services institutions that hold up to US$200B in assets. The solution will provide critical capabilities for monitoring, detecting, and investigating financial crime and risk to banks throughout the United States. The planned offering will help customers implement next generation technology, allowing them to keep up with the rapid pace of innovation and meet increasing compliance regulations. Quantexa is working with Microsoft to make an initial set of capabilities available by the end of 2024.

Dan Higgins, Chief Product Officer, Quantexa, said: Over the course of the last 12 months, decision intelligence has become a rapidly growing trend, as noted by multiple industry analysts. But decision intelligence has always been at our core since our inception. And at Quantexa, as we strive to innovate and evolve our technology offering to help enterprises and government agencies use contextual analytics and AI to improve decision making, I am thrilled to see our latest technology roadmap ring true to that. Our new partnership with Microsoft is testament to our commitment to providing our customers with accessible solutions, and we’ll continue to do more and to meet our customers where they need us.”

Tyler Pichach, Director of Financial Services Strategy at Microsoft, said: Financial Services organizations have become smarter and more efficient when it comes to successfully navigating shifting market dynamics. This is creating the need to use trusted data and AI to augment and automate the thousands of operational decisions they make daily when it comes to managing their data, tackling financial crime, or identifying new revenue opportunities. We are committed to working with partners like Quantexa to make its Decision Intelligence Platform available on Microsoft Azure Marketplace, bring new cloud native solutions to expanded market segments, and drive joint innovation to help our customers across multiple industries tackle some of their biggest challenges.”

To learn more about how your organization can put decision intelligence to work, or to read Forrester’s Total Economic Impact™ of the Quantexa Decision Intelligence Platform, visit here. To watch on-demand sessions from QuanCon24, visit the QuanCon website.

*Gartner, Predicts 2024: How Artificial Intelligence Will Impact Analytics Users, By Edgar Macari, Peter Krensky, Afraz Jaffri, David Pidsley, Aura Popa, Mike Fang, Rita Sallam, Julian Sun, Radu Miclaus, 4 January 2024.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

About Quantexa
Quantexa is a global data and analytics software company, pioneering decision intelligence that empowers organizations to make trusted operational decisions by making data meaningful. Using the latest advancements in big data and AI, Quantexa’s Decision Intelligence platform uncovers hidden risk and new opportunities by providing a contextual, connected view of internal and external data in a single place. It solves major challenges across data management, Know Your Customer (KYC), customer intelligence, financial crime, risk, fraud, and security, throughout the customer lifecycle.

The Quantexa Decision Intelligence Platform enhances operational performance with over 90 percent more accuracy and 60 times faster analytical model resolution than traditional approaches. Founded in 2016, Quantexa now has more than 700 employees and thousands of users working with billions of transactions and data points across the world. The company has offices in London, Dublin, Brussels, Malaga, UAE, New York, Boston, Toronto, Sydney, Melbourne, and Tokyo.

Media Inquiries

C: Stephanie Crisp, Associate Director and Media Strategist, Fight or Flight
E: Quantexa@fightflight.co.uk

C: Adam Jaffe, SVP of Corporate Marketing
T: +1 609 502 6889
E: adamjaffe@quantexa.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/36fa5c1e-cba8-4a4c-9272-191148c797aa

GlobeNewswire Distribution ID 1000928747

NAC signs MoU to expand aviation sector through ‘Air Connect Namibia’ project


WINDHOEK: The Namibia Airports Company (NAC) on Tuesday signed a Memorandum of Understanding (MoU) with key stakeholders aimed at fostering collaboration towards the expansion of the aviation sector through the launch of the ‘Air Connect Namibia’ project.

Speaking at the signing ceremony here, NAC Chief Executive Officer Bisey /Uirab said the aviation sector is a driver of the country’s economic activities and therefore there must be collaboration amongst key stakeholders to define the economic development and ensure that Namibia continues to play a role as the logistics hub in the region.

He explained that the project, amongst others, aims to target specific airlines to come to Namibia; formulate an air connectivity forum and have a broader air service development programme initiated.

‘The steering committee will have roles to play in ensuring that we have sufficient funding for this project so that we are able to do the work and to attract airlines and people who come to our country via air, as well as t
o ensure that we provide policy and strategic guidance to the industry,’ he said.

He noted that with the discovery of oil, and gas and the development of green hydrogen and other government initiatives, Namibia will need the air transport sector to come into play to ensure that travellers come to Namibia easily.

At the same event, NTB Acting Chief Executive Officer Bonnie Mbidzo said there is a need for Namibia to diversify its tourist arrivals through air connectivity as currently, the country relies heavily on German tourist arrivals.

‘We need to diversify into other markets but in those markets, we don’t have connectivity or airlift to Namibia and this project gives us that platform. Our statistics show that in the Netherlands, Belgium or east Europe the Italians the figures are there but connectivity to Namibia has been a problem,’ Mbidzo noted.

Equally, Director of Transport and Regulations in the Ministry of Works and Transport, Cedric Limbo said Namibia wants to become a logistical hub for the Sout
hern African Development Community (SADC) which will require efforts and initiatives such as the ‘Air Connect Namibia’.

‘The signed agreement will smoothen and fast-track the aspect of us becoming a logistical hub. Our aim as a government is really to urge our key stakeholders to unlock other markets. We should not only focus on the traditional markets, yes we have the Germans and the British but we need to unlock other markets,’ he noted.

The parties involved include the Namibia Tourism Board (NTB); the City of Windhoek (CoW); Gondwana Collection; Walvis Bay Corridor Group; the Namibia Chamber of Commerce and Industry, and the Namibia Investment Promotion Board.

Source: The Namibia Press Agency

Oshikoto looks up to NDP6 to solve water crisis


Oshikoto regional council chairperson, Samuel Shivute has urged the inhabitants of the region to pay close attention to the challenges they face, including the lack of clean water and recommend various solutions.

Shivute made the remarks during a regional consultative meeting held at Omuthiya by the National Planning Commission on the Sixth National Development Plan (NDP6) on Tuesday.

He said the region continues to experience a lack of water in most rural areas and there is a need for boreholes and upgrading of water treatment reservoirs and pipelines to ensure that the challenge is addressed.

Shivute also informed the meeting that the region lacks proper roads, more specifically feeder roads in most areas of Eengodi, Okankolo, omuntele, and Nehale lya Mpingana constituencies which hinder development as most of the services are inaccessible.

‘We have a high unemployment rate and a lack of school infrastructure mostly in the rural parts of the region such as classrooms and hostels, and tertiary institutio
ns,’ said Shivute.

NPC executive director (ED) Wilhencia Uiras said that they are in consultations with regional councils and all stakeholders both agents and beneficiaries of development to formulate the NDP6 through which the NPC spearheads and coordinates national socio-economic planning.

‘The NDP6 will be the last in the series towards Vision 2030 to be implemented from March 2025/2026 to March 2030/2031 financial years,’ said Uiras.

She said that the NDP6 calls for all stakeholders, agents, and beneficiaries of development to work together and leverage synergies in executing programmes and projects and discourages dependencies and recipient syndrome.

The Oshikoto Regional Council’s acting Chief Regional Officer, Peter Ndawedwa said that the region will play a crucial role in the implementation of the NDP6 by aligning regional development efforts with national priorities and coordinating development activities.

‘We will collaborate with relevant stakeholders to mobilise resources and implement infras
tructure projects effectively,’ said Ndawedwa.

Source: The Namibia Press Agency

Namibia Tourism Board promotes domestic tourismUutoni calls for collaboration among local authorities

WINDHOEK: The Namibia Tourism Board (NTB) is championing domestic tourism as part of a tourism revival initiative which involves members of the local media and social media influencers touring local establishments in central and western Namibia.

Scheduled for 11 to 18 March 2024, the familiarisation trip focuses on the central and western areas of Namibia.

NTB’s Head of Marketing, Charmaine Matthias on Monday outlined the board’s overarching goals and objectives in promoting Namibia as a premier tourism destination, both domestically and internationally.

She emphasised the importance of the initiative during which local media and influencers will promote tourism in Namibia by showcasing positive experiences during the trip.

‘Participants will explore a myriad of tourism products, ranging from picturesque wineries, breathtaking rugged mountains, ancient rock paintings, exhilarating surfing spots, vibrant cultural groups, diverse landscapes, tantalising cuisines, comfortable accommodations, to an array of t
ourism activities and scenic views,’ she said.

The selected travel dates strategically coincide with the period leading up to the Independence and Easter long weekends.

‘We aim to entice Namibian travellers with fresh ideas about the tourist attractions along this route, encouraging them to consider travelling before and during the upcoming holidays,’ Matthias said.

Highlighting the significance of local tourism, Matthias revealed that during the COVID-19 pandemic, only 4 per cent of Namibia’s tourism contributions came from domestic travellers. She encouraged Namibians to explore the tourism market within their own country, stressing the importance of supporting local businesses and experiencing the diverse offerings firsthand.

The familiarisation trip not only serves as a platform for the media and influencers to showcase Namibia’s tourism gems, but also aims to inspire and educate the local populace about the rich tapestry of attractions within their homeland.

With this proactive approach to domestic
tourism promotion, the Namibia Tourism Board is hoping to stimulate interest, encourage exploration, and foster a deeper appreciation for the country’s natural wonders, cultural heritage, and tourism offerings among its own citizens.

Source: The Namibia Press Agency

KEETMANSHOOP: Urban and Rural Development Minister Erastus Uutoni has said collaboration among municipalities, regional councils, and traditional authorities is essential and local authorities should not operate in isolation.

Uutoni made the remarks at the Association of Local Authorities in Namibia (ALAN) local economic development conference in Lderitz on Tuesday. He challenged the local authorities to share success stories, learn from each other’s challenges, and pool their resources.

‘We can address common issues such as accelerated land delivery, housing, sanitation and environmental sustainability. Let us foster a spirit of solidarity that transcends boundaries and benefits every Namibian,’ he said.

Uutoni said effective local economic development requires a holistic approach as it is not only limited to attracting foreign direct investment or building infrastructure, but involves an understanding of the unique needs of local communities, harnessing local talents and promoting sustainable practices.


Let us explore avenues for diversification, value addition and inclusive growth. Our rural areas, often overlooked, hold immense potential, let us therefore unlock that potential through targeted interventions and smart planning. That is why the national policy framework refers to regional and local economic development (LED) and not just LED, because there are integral links between rural and urban areas which we need to maximise,’ he said.

Uutoni further said while local authorities play a critical role in fostering sustainable growth, prosperity and well-being for citizens, local economic development is not merely an abstract concept, it is the lifeblood of towns, cities, and rural areas that drives job creation, infrastructure development, and social progress.

‘When our local economies thrive, so do the livelihoods of our people and that is why it is our collective duty to nurture an environment where businesses can flourish, innovation can thrive and opportunities can flourish,’ he said.

The three-day
meeting is aimed at providing an opportunity for stakeholders in the local economic sector to discuss and deliberate on matters that shape the future of their communities. It is being held under the theme ‘Promoting local economic development through, inclusive strategic planning, innovation and diversification of revenue streams’.

Source: The Namibia Press Agency

Minor allegedly rapes eight-year-old girl at Eengodi

ONAMISHU: The Namibian Police Force (NamPol) in the Oshikoto Region is looking for a boy, believed to be between the ages of 12 and 14, who is suspected of raping an eight-year-old girl.

According to NamPol’s Crime Investigations Coordinator for the Oshikoto Region, Deputy Commissioner Titus Ekandjo on Tuesday, the incident occurred last Thursday around 15h00 at Onamishu village in the Eengodi Constituency, but was only reported to the police on Monday.

‘It is alleged that the suspect found the victim walking alone on her way home from school. The suspect then grabbed the victim, asking to have sexual intercourse with the minor victim, and had sexual intercourse with her under coercive circumstances,’ Ekandjo said.

He added that the boy then fled into the bushes and the girl went home but did not tell her parents until her parents noticed that she was not walking properly.

‘Her aunt inspected her and found out that the victim was sexually assaulted,’ Ekandjo said.

Police investigations into the matter co
ntinue.

Source: The Namibia Press Agency

Namibia Tourism Board promotes domestic tourism

WINDHOEK: The Namibia Tourism Board (NTB) is championing domestic tourism as part of a tourism revival initiative which involves members of the local media and social media influencers touring local establishments in central and western Namibia.

Scheduled for 11 to 18 March 2024, the familiarisation trip focuses on the central and western areas of Namibia.

NTB’s Head of Marketing, Charmaine Matthias on Monday outlined the board’s overarching goals and objectives in promoting Namibia as a premier tourism destination, both domestically and internationally.

She emphasised the importance of the initiative during which local media and influencers will promote tourism in Namibia by showcasing positive experiences during the trip.

‘Participants will explore a myriad of tourism products, ranging from picturesque wineries, breathtaking rugged mountains, ancient rock paintings, exhilarating surfing spots, vibrant cultural groups, diverse landscapes, tantalising cuisines, comfortable accommodations, to an array of t
ourism activities and scenic views,’ she said.

The selected travel dates strategically coincide with the period leading up to the Independence and Easter long weekends.

‘We aim to entice Namibian travellers with fresh ideas about the tourist attractions along this route, encouraging them to consider travelling before and during the upcoming holidays,’ Matthias said.

Highlighting the significance of local tourism, Matthias revealed that during the COVID-19 pandemic, only 4 per cent of Namibia’s tourism contributions came from domestic travellers. She encouraged Namibians to explore the tourism market within their own country, stressing the importance of supporting local businesses and experiencing the diverse offerings firsthand.

The familiarisation trip not only serves as a platform for the media and influencers to showcase Namibia’s tourism gems, but also aims to inspire and educate the local populace about the rich tapestry of attractions within their homeland.

With this proactive approach to domestic
tourism promotion, the Namibia Tourism Board is hoping to stimulate interest, encourage exploration, and foster a deeper appreciation for the country’s natural wonders, cultural heritage, and tourism offerings among its own citizens.

Source: The Namibia Press Agency

Traditional knowledge of genetic resources overlooked: Iipumbu

Many communities have understood the properties of genetic resources for centuries and their traditional knowledge systems hold invaluable insight into their medicinal properties.

This is according to Minister of Industrialisation and Trade Lucia Iipumbu, who said the current global framework for intellectual property often fails to recognise the contributions of these communities, a situation which should be addressed.

Iipumbu in a speech delivered on her behalf at the opening of the Cross Regional Meeting on Intellectual Property, Genetic Resources and Traditional Knowledge in Swakopmund emphasised the immense potential held by the wealth of genetic resources to the world.

The meeting which commenced on Tuesday is organised by the Business and Intellectual Property Authority (BIPA), in collaboration with the World Intellectual Property Organisation (WIPO), in preparation for the Diplomatic Conference for the adoption of the International Instrument for Protection of Genetic Resources and Traditional Know
ledge associated with the use of Genetic Resources, to be held in May 2024.

The objective of the meeting is to provide an opportunity for member states from all groups to discuss the basic proposal.

‘From the vast biodiversity of the Namib Desert to the fertile rainforests of the Congo Basin, Africa is a treasure trove of genetic material. This biodiversity is not just a collection of plants and animals; but rather a cherished fact that this too is rooted in the traditional knowledge of our people, often carried over from generation to generation,’ she expressed.

BIPA Chief Executive Officer Vivienne Katjiuongua underscored the importance of addressing the complex interplay between intellectual property and genetic resources, and the need for a robust international instrument that strikes a balance between promoting innovation and safeguarding the rights of indigenous communities.

‘Namibia has been very proactive in the development of legal and policy frameworks to protect traditional knowledge and geneti
c resources, which include the Access and Benefit-Sharing framework, aiming to ensure equitable sharing of benefits derived from the use of genetic resources and associated traditional knowledge,’ Katjiuongua highlighted.

The meeting is being attended by more than 60 delegates comprising Group Coordinators plus five other delegates from each regional group in WIPO.

It ends on Thursday.

Source: The Namibia Press Agency

NSI consults Omaheke on National Standardisation Strategy

The Namibian Standards Institution (NSI) held a consultative meeting in Gobabis on Tuesday to discuss the proposed National Standardisation Strategy with its different stakeholders.

The National Standardization Strategy is a need-based guideline document that identifies key priority sectors for standardisation needs and through its consultations, NSI aims to gather data that will be used to compile the National Standards Plan.

Officiating the meeting Karukirue Tjijenda the Omaheke regional Development and Planning Director in a speech delivered on his behalf expressed gratitude to the National Standardisation Strategy Task Force for having worked tirelessly in responding to the national request to coordinate the development of the National Standardization Strategy document.

‘I would like to convey my gratitude to all international, continental and regional partners for their continuous financial and technical support in the realization of this enormous project on behalf of the Namibian government in genera
l and the Ministry of Industrialization and Trade in particular, he noted.

The National Standardisation Strategy development as part of the broader National Quality Policy implementation is a positive government intervention that highlights its strategic intent and commitment in pursuit of quality excellence and enhancement across all sectors of the Namibian economy,’ he said.

Tjijenda noted that by being the National Standard Body for Namibia, the NSI would continue to promote standardisation of commodities for the safety of consumers, protection of the environment and improved access to global markets.

The National Standardisation Strategy Task Force Secretary, Nelson Tjihozu, highlighted that consultation is very important and participation from stakeholders is also very crucial as this helps in the implementation of strategies.

‘We are in the process of developing the National Standardisation Strategy, thus, you are the ones to tell us in your specific sectors and sub-sectors or fields what your prior
ities standards are from the Omaheke region,’ he indicated.

Source: The Namibia Press Agency